aluates Reports

$ 0.0

Automative

Global Veterinary Vaccine Adjuvants Market Research Report 2026

Published Date: 2026-01-15

Report Code: QYRE-Auto-4Y9119

Global Veterinary Vaccine Adjuvants Market Outlook 2022

BUY CHAPTERS

Global Veterinary Vaccine Adjuvants Market Research Report 2026

Code: QYRE-Auto-4Y9119

Report

2026-01-15

Pages:117

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

SEPPIC

SDA BIO

SPI Pharma

CRODA

Phibro Animal Health

Vertellus

Veterinary Vaccine Adjuvants Market Size

The global Veterinary Vaccine Adjuvants market was valued at US$ 373 million in 2025 and is anticipated to reach US$ 593 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Veterinary Vaccine Adjuvants Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Veterinary Vaccine Adjuvants competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Veterinary vaccine adjuvants are auxiliary substances used together with antigens in animal vaccines (either concurrently or as a pre-treatment) to enhance or modulate the immune response of the host to these antigens. Compared with traditional vaccines relying solely on antigen content, adjuvants significantly improve immune protection for livestock, poultry, pets, and aquatic animals by prolonging antigen persistence in the body, enhancing antigen presentation, activating innate immune pathways, and stimulating lymphocyte proliferation and differentiation. These adjuvants are compatible with inactivated vaccines, recombinant vaccines, subunit vaccines and emerging vaccine platforms. In 2024, global Veterinary vaccine adjuvants production reached approximately 20 million L, with an average global market price of around US$ 17.4 per L.The average gross profit margin of this product is 43%.

The veterinary vaccine adjuvants market is currently at a rapid growth stage, driven fundamentally by a significant rise in global demand for animal health, preventive vaccination, and animal‑derived food safety. First, expanding population and growing consumption of animal protein have led to larger scale livestock farming, raising the importance of disease prevention — in turn boosting demand for high‑performance vaccines and adjuvants. Second, the steady growth in companion animals (pets) — increasing pet ownership and stronger pet‑health awareness — drives demand for preventive vaccination and premium immune solutions, thereby raising demand for safe, high‑efficacy adjuvants. Third, advances in biotechnology, nanotechnology, lipid‑based delivery systems and novel adjuvant research enable newer vaccine platforms (e.g. recombinant, subunit) to achieve robust immune responses via adjuvants, opening huge opportunities for next‑generation adjuvants. Finally, growing attention by governments and public health authorities to animal epidemic control, zoonosis prevention, and food‑security regulation brings policy support and market validation to the industry. Altogether, these forces create a “golden window” of high growth, high investment and high return potential for veterinary vaccine adjuvants.

However, despite favorable prospects, the veterinary vaccine adjuvant industry faces substantial challenges and risks. First, stringent regulation and high safety/efficacy requirements — different animal species and vaccine types impose varied tolerances, thus novel adjuvants must undergo rigorous validation, which prolongs development cycles and raises R&D and registration costs. Second, traditional adjuvants (e.g. mineral‑based) have limitations in inducing strong T‑cell responses and long‑lasting immunity, which means their utility is diminishing when dealing with modern highly purified or novel vaccines; development of advanced adjuvants (lipid, nanoparticle, polysaccharide, saponin-based) requires significant investment, while raw materials may face supply, purity or stability issues. Third, in many developing regions, awareness and acceptance of advanced adjuvant‑based vaccines remain low; basic or traditional vaccines still dominate, limiting market penetration. Lastly, market concentration is increasing: a few established players with strong R&D, regulatory and scale advantages control major share, creating high entry barriers; this may inhibit smaller or innovative companies and slow down overall innovation adoption.

On the downstream side, demand patterns for veterinary vaccine adjuvants are evolving significantly. In livestock and poultry sectors, demand for high‑efficacy vaccines continues to rise, especially in intensive farming and large‑scale poultry operations, where adjuvants become essential for efficient herd immunity and reduced vaccination frequency. The companion animal segment (pets) remains a stable and fast‑growing market, as pet owners increasingly prioritize preventive healthcare and are willing to pay for higher safety and efficacy — driving demand for adjuvanted pet vaccines. Beyond traditional intramuscular injection vaccines, the industry is exploring mucosal (e.g. nasal, oral) or more convenient delivery routes. These routes require adjuvants with high safety, stability and good immunostimulatory profiles, thereby spurring demand for advanced adjuvant formulations. Overall, downstream demand is shifting from simple disease prevention toward comprehensive animal health management, production efficiency enhancement for livestock, and pet health maintenance — offering broad and diversified application scenarios for adjuvant manufacturers.

The upstream raw materials for veterinary vaccine adjuvants cover a range of traditional and advanced components, including mineral salts (e.g. aluminum salts), lipids/liposomes, polymeric or carbomer systems, nanoparticles, saponins, polysaccharides, and other biocompatible carrier materials. Conventional mineral‑based adjuvants remain prevalent due to low cost, mature manufacturing processes and historical regulatory acceptance, but their capacity to induce strong T‑cell mediated immunity or support long‑lasting protective responses is limited — creating a bottleneck for modern vaccine demands. Newer materials — lipid carriers, oil-in-water or water-in-oil emulsions, polymer/nanoparticle systems — enable precise antigen delivery, sustained release, and stronger immune activation, and are increasingly favored. Moreover, sustainable, plant‑derived or polysaccharide/saponin-based adjuvants (e.g. QS‑21) are gaining attention, especially for pet and poultry vaccines where safety and environmental impact matter. However, these advanced raw materials present challenges in supply chain stability, extraction/purification consistency, batch-to-batch repeatability, and compliance with regulatory standards. Ultimately, the diversity and technological maturity of upstream raw materials will determine whether a manufacturer can secure differentiation and leadership in the evolving adjuvant market.

This report delivers a comprehensive overview of the global Veterinary Vaccine Adjuvants market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Veterinary Vaccine Adjuvants. The Veterinary Vaccine Adjuvants market size, estimates, and forecasts are provided in terms of sales volume (K L) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Veterinary Vaccine Adjuvants market comprehensively. Regional market sizes by Type, by Application, by Functional Purpose, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Veterinary Vaccine Adjuvants manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Veterinary Vaccine Adjuvants Market Report

Report Metric	Details
Report Name	Veterinary Vaccine Adjuvants Market
Accounted market size in 2025	US$ 373 million
Forecasted market size in 2032	US$ 593 million
CAGR	6.9%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Emulsion Adjuvants Mineral Adjuvants Others
Segment by Functional Purpose	Immune Enhancement Immune Modulation Other
Segment by Compatible Vaccine Type	Inactivated Vaccine Live Attenuated Vaccine Subunit Vaccine Other
by Application	Livestock Vaccines Companion Animals Vaccines
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Functional Purpose, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Veterinary Vaccine Adjuvants manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Veterinary Vaccine Adjuvants sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Veterinary Vaccine Adjuvants Market growing?

Ans: The Veterinary Vaccine Adjuvants Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Veterinary Vaccine Adjuvants Market size in 2032?

Ans: The Veterinary Vaccine Adjuvants Market size in 2032 will be US$ 593 million.

Who are the main players in the Veterinary Vaccine Adjuvants Market report?

Ans: The main players in the Veterinary Vaccine Adjuvants Market are SEPPIC, SDA BIO, Croda, SPI Pharma, Phibro Animal Health, Vertellus

What are the Application segmentation covered in the Veterinary Vaccine Adjuvants Market report?

Ans: The Applications covered in the Veterinary Vaccine Adjuvants Market report are Livestock Vaccines, Companion Animals Vaccines

What are the Type segmentation covered in the Veterinary Vaccine Adjuvants Market report?

Ans: The Types covered in the Veterinary Vaccine Adjuvants Market report are Inactivated Vaccine, Live Attenuated Vaccine, Subunit Vaccine, Other

1 Veterinary Vaccine Adjuvants Market Overview

1.1 Product Definition

1.2 Veterinary Vaccine Adjuvants by Type

1.2.1 Global Veterinary Vaccine Adjuvants Market Value by Type: 2025 vs 2032

1.2.2 Emulsion Adjuvants

1.2.3 Mineral Adjuvants

1.2.4 Others

1.3 Veterinary Vaccine Adjuvants by Functional Purpose

1.3.1 Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose: 2025 vs 2032

1.3.2 Immune Enhancement

1.3.3 Immune Modulation

1.3.4 Other

1.4 Veterinary Vaccine Adjuvants by Compatible Vaccine Type

1.4.1 Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type: 2025 vs 2032

1.4.2 Inactivated Vaccine

1.4.3 Live Attenuated Vaccine

1.4.4 Subunit Vaccine

1.4.5 Other

1.5 Veterinary Vaccine Adjuvants by Application

1.5.1 Global Veterinary Vaccine Adjuvants Market Value by Application: 2025 vs 2032

1.5.2 Livestock Vaccines

1.5.3 Companion Animals Vaccines

1.6 Global Veterinary Vaccine Adjuvants Market Size Estimates and Forecasts

1.6.1 Global Veterinary Vaccine Adjuvants Revenue 2021–2032

1.6.2 Global Veterinary Vaccine Adjuvants Sales 2021–2032

1.6.3 Global Veterinary Vaccine Adjuvants Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Veterinary Vaccine Adjuvants Market Competition by Manufacturers

2.1 Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)

2.2 Global Veterinary Vaccine Adjuvants Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Veterinary Vaccine Adjuvants Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications

2.7 Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry

2.8 Global Veterinary Vaccine Adjuvants Market Competitive Situation and Trends

2.8.1 Global Veterinary Vaccine Adjuvants Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players Market Share by Revenue

2.8.3 Global Veterinary Vaccine Adjuvants Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Veterinary Vaccine Adjuvants Market Scenario by Region

3.1 Global Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2032

3.2.1 Global Veterinary Vaccine Adjuvants Sales by Region: 2021–2026

3.2.2 Global Veterinary Vaccine Adjuvants Sales by Region: 2027–2032

3.3 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2032

3.3.1 Global Veterinary Vaccine Adjuvants Revenue by Region: 2021–2026

3.3.2 Global Veterinary Vaccine Adjuvants Revenue by Region: 2027–2032

3.4 North America Veterinary Vaccine Adjuvants Market Facts & Figures by Country

3.4.1 North America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)

3.4.3 North America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Veterinary Vaccine Adjuvants Market Facts & Figures by Country

3.5.1 Europe Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Veterinary Vaccine Adjuvants Sales by Country (2021–2032)

3.5.3 Europe Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Veterinary Vaccine Adjuvants Market Facts & Figures by Region

3.6.1 Asia Pacific Veterinary Vaccine Adjuvants Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (2021–2032)

3.6.3 Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Veterinary Vaccine Adjuvants Market Facts & Figures by Country

3.7.1 Latin America Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Veterinary Vaccine Adjuvants Sales by Country (2021–2032)

3.7.3 Latin America Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Veterinary Vaccine Adjuvants Market Facts & Figures by Country

3.8.1 Middle East and Africa Veterinary Vaccine Adjuvants Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (2021–2032)

3.8.3 Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2032)

4.1.1 Global Veterinary Vaccine Adjuvants Sales by Type (2021–2026)

4.1.2 Global Veterinary Vaccine Adjuvants Sales by Type (2027–2032)

4.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2032)

4.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2032)

4.2.1 Global Veterinary Vaccine Adjuvants Revenue by Type (2021–2026)

4.2.2 Global Veterinary Vaccine Adjuvants Revenue by Type (2027–2032)

4.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2032)

4.3 Global Veterinary Vaccine Adjuvants Price by Type (2021–2032)

5 Segment by Application

5.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2032)

5.1.1 Global Veterinary Vaccine Adjuvants Sales by Application (2021–2026)

5.1.2 Global Veterinary Vaccine Adjuvants Sales by Application (2027–2032)

5.1.3 Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2032)

5.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2032)

5.2.1 Global Veterinary Vaccine Adjuvants Revenue by Application (2021–2026)

5.2.2 Global Veterinary Vaccine Adjuvants Revenue by Application (2027–2032)

5.2.3 Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2032)

5.3 Global Veterinary Vaccine Adjuvants Price by Application (2021–2032)

6 Key Companies Profiled

6.1 SEPPIC

6.1.1 SEPPIC Company Information

6.1.2 SEPPIC Description and Business Overview

6.1.3 SEPPIC Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 SEPPIC Veterinary Vaccine Adjuvants Product Portfolio

6.1.5 SEPPIC Recent Developments/Updates

6.2 SDA BIO

6.2.1 SDA BIO Company Information

6.2.2 SDA BIO Description and Business Overview

6.2.3 SDA BIO Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 SDA BIO Veterinary Vaccine Adjuvants Product Portfolio

6.2.5 SDA BIO Recent Developments/Updates

6.3 Croda

6.3.1 Croda Company Information

6.3.2 Croda Description and Business Overview

6.3.3 Croda Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Croda Veterinary Vaccine Adjuvants Product Portfolio

6.3.5 Croda Recent Developments/Updates

6.4 SPI Pharma

6.4.1 SPI Pharma Company Information

6.4.2 SPI Pharma Description and Business Overview

6.4.3 SPI Pharma Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 SPI Pharma Veterinary Vaccine Adjuvants Product Portfolio

6.4.5 SPI Pharma Recent Developments/Updates

6.5 Phibro Animal Health

6.5.1 Phibro Animal Health Company Information

6.5.2 Phibro Animal Health Description and Business Overview

6.5.3 Phibro Animal Health Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Phibro Animal Health Veterinary Vaccine Adjuvants Product Portfolio

6.5.5 Phibro Animal Health Recent Developments/Updates

6.6 Vertellus

6.6.1 Vertellus Company Information

6.6.2 Vertellus Description and Business Overview

6.6.3 Vertellus Veterinary Vaccine Adjuvants Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Vertellus Veterinary Vaccine Adjuvants Product Portfolio

6.6.5 Vertellus Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Veterinary Vaccine Adjuvants Industry Chain Analysis

7.2 Veterinary Vaccine Adjuvants Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Veterinary Vaccine Adjuvants Production Mode & Process Analysis

7.4 Veterinary Vaccine Adjuvants Sales and Marketing

7.4.1 Veterinary Vaccine Adjuvants Sales Channels

7.4.2 Veterinary Vaccine Adjuvants Distributors

7.5 Veterinary Vaccine Adjuvants Customer Analysis

8 Veterinary Vaccine Adjuvants Market Dynamics

8.1 Veterinary Vaccine Adjuvants Industry Trends

8.2 Veterinary Vaccine Adjuvants Market Drivers

8.3 Veterinary Vaccine Adjuvants Market Challenges

8.4 Veterinary Vaccine Adjuvants Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SEPPIC

SDA BIO

SPI Pharma

CRODA

Phibro Animal Health

Vertellus

List of Tables

Table 1. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2025 vs 2032

Table 3. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2025 vs 2032

Table 4. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Veterinary Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2025

Table 6. Global Veterinary Vaccine Adjuvants Sales (K L) of Key Manufacturers (2021–2026)

Table 7. Global Veterinary Vaccine Adjuvants Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Veterinary Vaccine Adjuvants Average Price (USD/L) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Veterinary Vaccine Adjuvants, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Product Types and Applications

Table 14. Global Key Manufacturers of Veterinary Vaccine Adjuvants, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Veterinary Vaccine Adjuvants Companies by Tier (Tier 1, Tier 2, Tier 3), based on Veterinary Vaccine Adjuvants Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026

Table 20. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2026)

Table 21. Global Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032

Table 22. Global Veterinary Vaccine Adjuvants Sales Market Share by Region (2027–2032)

Table 23. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026

Table 24. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2026)

Table 25. Global Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032

Table 26. Global Veterinary Vaccine Adjuvants Revenue Market Share by Region (2027–2032)

Table 27. North America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026

Table 29. North America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032

Table 30. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026

Table 31. North America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026

Table 34. Europe Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032

Table 35. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2021–2026

Table 39. Asia Pacific Veterinary Vaccine Adjuvants Sales by Region (K L), 2027–2032

Table 40. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Veterinary Vaccine Adjuvants Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026

Table 44. Latin America Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032

Table 45. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2021–2026

Table 49. Middle East and Africa Veterinary Vaccine Adjuvants Sales by Country (K L), 2027–2032

Table 50. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Veterinary Vaccine Adjuvants Revenue by Country (US$ Million), 2027–2032

Table 52. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2021–2026)

Table 53. Global Veterinary Vaccine Adjuvants Sales (K L) by Type (2027–2032)

Table 54. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2021–2026)

Table 55. Global Veterinary Vaccine Adjuvants Sales Market Share by Type (2027–2032)

Table 56. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2021–2026)

Table 59. Global Veterinary Vaccine Adjuvants Revenue Market Share by Type (2027–2032)

Table 60. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2026)

Table 61. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2027–2032)

Table 62. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2021–2026)

Table 63. Global Veterinary Vaccine Adjuvants Sales (K L) by Application (2027–2032)

Table 64. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2021–2026)

Table 65. Global Veterinary Vaccine Adjuvants Sales Market Share by Application (2027–2032)

Table 66. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Veterinary Vaccine Adjuvants Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2021–2026)

Table 69. Global Veterinary Vaccine Adjuvants Revenue Market Share by Application (2027–2032)

Table 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2026)

Table 71. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2027–2032)

Table 72. SEPPIC Company Information

Table 73. SEPPIC Description and Business Overview

Table 74. SEPPIC Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 75. SEPPIC Veterinary Vaccine Adjuvants Product

Table 76. SEPPIC Recent Developments/Updates

Table 77. SDA BIO Company Information

Table 78. SDA BIO Description and Business Overview

Table 79. SDA BIO Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 80. SDA BIO Veterinary Vaccine Adjuvants Product

Table 81. SDA BIO Recent Developments/Updates

Table 82. Croda Company Information

Table 83. Croda Description and Business Overview

Table 84. Croda Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 85. Croda Veterinary Vaccine Adjuvants Product

Table 86. Croda Recent Developments/Updates

Table 87. SPI Pharma Company Information

Table 88. SPI Pharma Description and Business Overview

Table 89. SPI Pharma Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 90. SPI Pharma Veterinary Vaccine Adjuvants Product

Table 91. SPI Pharma Recent Developments/Updates

Table 92. Phibro Animal Health Company Information

Table 93. Phibro Animal Health Description and Business Overview

Table 94. Phibro Animal Health Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 95. Phibro Animal Health Veterinary Vaccine Adjuvants Product

Table 96. Phibro Animal Health Recent Developments/Updates

Table 97. Vertellus Company Information

Table 98. Vertellus Description and Business Overview

Table 99. Vertellus Veterinary Vaccine Adjuvants Sales (K L), Revenue (US$ Million), Price (USD/L), and Gross Margin (2021–2026)

Table 100. Vertellus Veterinary Vaccine Adjuvants Product

Table 101. Vertellus Recent Developments/Updates

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Veterinary Vaccine Adjuvants Distributors List

Table 105. Veterinary Vaccine Adjuvants Customers List

Table 106. Veterinary Vaccine Adjuvants Market Trends

Table 107. Veterinary Vaccine Adjuvants Market Drivers

Table 108. Veterinary Vaccine Adjuvants Market Challenges

Table 109. Veterinary Vaccine Adjuvants Market Restraints

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

Table 113. Authors List of This Report

List of Figures

Figure 1. Product Picture of Veterinary Vaccine Adjuvants

Figure 2. Global Veterinary Vaccine Adjuvants Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Veterinary Vaccine Adjuvants Market Share by Type: 2025 & 2032

Figure 4. Emulsion Adjuvants Product Picture

Figure 5. Mineral Adjuvants Product Picture

Figure 6. Others Product Picture

Figure 7. Global Veterinary Vaccine Adjuvants Market Value by Functional Purpose (US$ Million), 2021–2032

Figure 8. Global Veterinary Vaccine Adjuvants Market Share by Functional Purpose: 2025 vs 2032

Figure 9. Immune Enhancement Product Picture

Figure 10. Immune Modulation Product Picture

Figure 11. Other Product Picture

Figure 12. Global Veterinary Vaccine Adjuvants Market Value by Compatible Vaccine Type (US$ Million), 2021–2032

Figure 13. Global Veterinary Vaccine Adjuvants Market Share by Compatible Vaccine Type: 2025 vs 2032

Figure 14. Inactivated Vaccine Product Picture

Figure 15. Live Attenuated Vaccine Product Picture

Figure 16. Subunit Vaccine Product Picture

Figure 17. Other Product Picture

Figure 18. Global Veterinary Vaccine Adjuvants Market Value by Application (US$ Million), 2021–2032

Figure 19. Global Veterinary Vaccine Adjuvants Market Share by Application: 2025 & 2032

Figure 20. Livestock Vaccines

Figure 21. Companion Animals Vaccines

Figure 22. Global Veterinary Vaccine Adjuvants Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Veterinary Vaccine Adjuvants Market Size (US$ Million), 2021–2032

Figure 24. Global Veterinary Vaccine Adjuvants Sales (K L), 2021–2032

Figure 25. Global Veterinary Vaccine Adjuvants Average Price (USD/L), 2021–2032

Figure 26. Veterinary Vaccine Adjuvants Report Years Considered

Figure 27. Veterinary Vaccine Adjuvants Sales Share by Manufacturers in 2025

Figure 28. Global Veterinary Vaccine Adjuvants Revenue Share by Manufacturers in 2025

Figure 29. Top 5 and Top 10 Global Veterinary Vaccine Adjuvants Players: Market Share by Revenue in Veterinary Vaccine Adjuvants in 2025

Figure 30. Veterinary Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 31. Global Veterinary Vaccine Adjuvants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 32. North America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)

Figure 33. North America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)

Figure 34. U.S. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Canada Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Europe Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)

Figure 37. Europe Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)

Figure 38. Germany Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. France Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. U.K. Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Italy Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Russia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Asia Pacific Veterinary Vaccine Adjuvants Sales Market Share by Region (2021–2032)

Figure 44. Asia Pacific Veterinary Vaccine Adjuvants Revenue Market Share by Region (2021–2032)

Figure 45. China Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Japan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. South Korea Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. India Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Australia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Taiwan Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Indonesia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Thailand Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Malaysia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Philippines Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Latin America Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)

Figure 56. Latin America Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)

Figure 57. Mexico Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Brazil Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Argentina Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. Middle East and Africa Veterinary Vaccine Adjuvants Sales Market Share by Country (2021–2032)

Figure 61. Middle East and Africa Veterinary Vaccine Adjuvants Revenue Market Share by Country (2021–2032)

Figure 62. Turkey Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Saudi Arabia Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 64. U.A.E Veterinary Vaccine Adjuvants Revenue Growth Rate (US$ Million), 2021–2032

Figure 65. Global Sales Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)

Figure 66. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Type (2021–2032)

Figure 67. Global Veterinary Vaccine Adjuvants Price (USD/L) by Type (2021–2032)

Figure 68. Global Sales Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)

Figure 69. Global Revenue Market Share of Veterinary Vaccine Adjuvants by Application (2021–2032)

Figure 70. Global Veterinary Vaccine Adjuvants Price (USD/L) by Application (2021–2032)

Figure 71. Veterinary Vaccine Adjuvants Value Chain

Figure 72. Channels of Distribution (Direct Vs Distribution)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Biological Vaccines Adjuvants Market Research Report 2025

Global Mineral based Adjuvants Market Research Report 2024

Immunostimulatory Adjuvants Market

Global Adjuvanted Influenza Vaccine Market Research Report 2024

Global Dog Vaccines Market Insights Forecast to 2030

Global Oral Vaccine Adjuvants Market Research Report 2025

Veterinary Vaccine Market

Global Veterinary Vaccination Market Research Report 2025

Global Travelers Vaccination Market Research Report 2025

Global Travelers Vaccines Market Research Report 2025

Global Livestock Vaccines Market Research Report 2025

Global Human Vaccination Market Research Report 2025

Global Oncology Adjuvants Market Insights Forecast to 2030

Global Intramuscular Vaccine Adjuvants Market Research Report 2025

Global Livestock Animal Vaccination Market Research Report 2025

Global Livestock Animal Vaccines Market Research Report 2024

Global Cat Vaccines Market Insights Forecast to 2030

Global Veterinary Biological Vaccines Market Research Report 2025

Global Human Vaccine Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions